Revaccination at 12 months with the investigational respiratory syncytial virus (RSV) vaccine mRNA-1345 is well tolerated and supported for eligible older adults, according to study results presented ...
Nearly six months after lodging a similar complaint against Pfizer and BioNTech over the partners’ COVID shot Comirnaty, GSK ...
The lawsuits claim that Moderna used and profited from crucial mRNA technology in its COVID-19 vaccine Spikevax and ...
A vaccine is to be trialled on thousands of people to find out if it could protect against norovirus - a stomach bug that ...
Scripps News on MSN6d
British drugmaker sues Moderna for patent infringement related to mRNA vaccinesA British drugmaker, GlaxoSmithKline (GSK), has sued American pharmaceutical company Moderna claiming it violated patent ...
(Reuters) -British drugmaker GlaxoSmithKline sued Moderna in U.S. federal court in Delaware on Tuesday, accusing it of ...
GSK filed two lawsuits at the US District of Delaware on 15 October saying that Moderna’s mRNA vaccine product Spikevax ...
Moderna Inc.’s shots for Covid-19 and respiratory syncytial virus infringe as many as seven GSK Plc patents related to mRNA ...
A new trial that aims to protect against norovirus, a highly contagious stomach bug that causes vomiting and diarrhoea, is ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback